X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (65) 65
physics (51) 51
high energy physics - experiment (50) 50
experiment (49) 49
物理学 (48) 48
oncology (46) 46
fysik (45) 45
male (45) 45
natural sciences (45) 45
naturvetenskap (45) 45
particle physics (45) 45
physical sciences (45) 45
physics of elementary particles and fields (45) 45
carcinoma, renal cell - drug therapy (42) 42
female (42) 42
physics - high energy physics - experiment (40) 40
kidney neoplasms - drug therapy (39) 39
middle aged (38) 38
cancer (34) 34
physics, particles & fields (32) 32
aged (31) 31
carcinoma, renal cell (31) 31
metastasis (31) 31
urology & nephrology (31) 31
sunitinib (30) 30
kidney neoplasms - pathology (29) 29
treatment outcome (26) 26
care and treatment (25) 25
elementary particles, quantum field theory (25) 25
hep (25) 25
high energy physics (25) 25
large hadron collider (25) 25
prognosis (25) 25
quantum field theories, string theory (25) 25
renal cell carcinoma (25) 25
survival (24) 24
interferon-alpha (23) 23
retrospective studies (23) 23
antineoplastic agents - therapeutic use (22) 22
carcinoma, renal cell - mortality (22) 22
targeted therapy (22) 22
urology (22) 22
kidney neoplasms - mortality (21) 21
astronomy, astrophysics and cosmology (20) 20
carcinoma, renal cell - secondary (20) 20
adult (19) 19
collisions (19) 19
disease-free survival (19) 19
measurement science and instrumentation (19) 19
nuclear energy (19) 19
nuclear experiment (19) 19
nuclear physics, heavy ions, hadrons (19) 19
subatomic physics (19) 19
subatomär fysik (19) 19
aged, 80 and over (18) 18
everolimus (18) 18
hematology, oncology and palliative medicine (18) 18
sorafenib (18) 18
analysis (16) 16
article (16) 16
particle collisions (16) 16
regular - experimental physics (16) 16
neoplasm metastasis (15) 15
patient outcomes (15) 15
vascular endothelial growth factor (15) 15
carcinoma, renal cell - pathology (14) 14
indoles - therapeutic use (13) 13
molecular targeted therapy (13) 13
phenomenology (13) 13
pyrroles - therapeutic use (13) 13
risk factors (13) 13
transverse momentum (13) 13
vascular endothelial growth factor a - antagonists & inhibitors (13) 13
detectors (12) 12
kaplan-meier estimate (12) 12
luminosity (12) 12
model (12) 12
antineoplastic agents (11) 11
databases, factual (11) 11
survival analysis (11) 11
survival rate (11) 11
abridged index medicus (10) 10
hadron (10) 10
quarks (10) 10
research (10) 10
trial (10) 10
antimitotic agents (9) 9
bevacizumab (9) 9
double-blind (9) 9
leptons (9) 9
molecular targeted therapy - methods (9) 9
niacinamide - analogs & derivatives (9) 9
parton distributions (9) 9
phase-iii trial (9) 9
protons (9) 9
standard model (9) 9
time factors (9) 9
astronomy & astrophysics (8) 8
astrophysics (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2018, Volume 36, Issue 36, pp. 3567 - 3573
The most common type of cancer originating in the kidney is renal cell carcinoma (RCC). In both localized and advanced RCC, a number of clinical, pathologic,... 
TARGETED THERAPY | RADICAL NEPHRECTOMY | SURVIVAL | IMPACT | ONCOLOGY | HIGH-RISK | VALIDATION | MODEL | RETROSPECTIVE ANALYSIS | RENAL-CELL CARCINOMA | ADJUVANT SUNITINIB
Journal Article
Current Opinion in Urology, ISSN 0963-0643, 09/2019, Volume 29, Issue 5, pp. 507 - 512
PURPOSE OF REVIEWTo review the evidence related to cytoreductive nephrectomy in metastatic renal cell carcinoma (mRCC) treated in the targeted therapy era,... 
Care and treatment | Carcinoma, Renal cell | Metastasis | Nephrectomy | Patient outcomes | Index Medicus
Journal Article
The Oncologist, ISSN 1083-7159, 12/2017, Volume 22, Issue 12, pp. 1561 - 1561
This letter responds to the letter from Tan et al., noting points of agreement and encouraging efforts to share genomic signatures and codes that will make... 
Letters to the Editor
Journal Article
The Oncologist, ISSN 1083-7159, 12/2017, Volume 22, Issue 12, pp. 1561 - 1561
This letter responds to the letter from Tan et al., noting points of agreement and encouraging efforts to share genomic signatures and codes that will make... 
Journal Article
The Oncologist, ISSN 1083-7159, 12/2017, Volume 22, Issue 12, pp. 1561 - 1561
Journal Article
European urology, 08/2019
BACKGROUNDIn metastatic renal-cell carcinoma (mRCC), recent data have shown efficacy of first-line ipilimumab and nivolumab (ipi-nivo) as well as... 
Index Medicus
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 07/2017, Volume 13, Issue 7, pp. 422 - 423
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 02/2014, Volume 143, Issue 3, p. 459
The present exploratory analysis examined the efficacy, safety, and quality-of-life effects of everolimus (EVE) + exemestane (EXE) in the subgroup of patients... 
Care and treatment | Breast cancer | Postmenopausal women | Angiogenesis inhibitors | Analysis
Journal Article
Clinical Genitourinary Cancer, ISSN 1558-7673, 2017
Abstract Background A significant minority of metastatic Renal Cell Carcinoma (mRCC) patients discontinue vascular endothelial growth factor-targeted therapies... 
Hematology, Oncology and Palliative Medicine | Urology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.